Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified. more
| Time Frame | OZEM | S&P500 |
|---|---|---|
| 1-Week Return | 2.91% | 1.24% |
| 1-Month Return | 1.88% | 4.94% |
| 3-Month Return | -7.32% | 9.34% |
| 6-Month Return | -5.78% | 9.8% |
| 1-Year Return | 27.11% | 26.99% |
| 3-Year Return | 23.81% | 78.76% |
| Time Frame | OZEM | S&P500 |
|---|---|---|
| 1-Week Return | 346.25% | 90.14% |
| 1-Month Return | 25.43% | 79.80% |
| 3-Month Return | -26.53% | 43.64% |
| 6-Month Return | -11.37% | 20.87% |
| 1-Year Return | 27.11% | 26.99% |
| 3-Year Return | 7.38% | 21.36% |
| Stock name | Ticker | Weight |
|---|---|---|
Eli Lilly & Co | LLY | 17.42% |
Novo Nordisk A/S | NVO | 13% |
Pfizer Inc | PFE | 6.45% |
Viking Therapeutics Inc | VKTX | 4.58% |
CSPC Pharmaceutical Group Ltd | 1093.HK | 4.48% |
Chugai Pharmaceutical Co Ltd | 4519.T | 4.32% |
Kailera Therapeutics Inc | KLRA | 4.15% |
Zealand Pharma A/S | ZEAL.CO | 4.06% |
Innovent Biologics Inc | 1801.HK | 4.03% |
Hanmi Pharm Co Ltd | 128940.KS | 3.62% |
Amgen Inc | AMGN | 3.6% |
Ascletis Pharma Inc | 1672.HK | 3.52% |
AstraZeneca PLC | AZN | 3.42% |
Roche Holding AG | ROP.SW | 2.9% |
Regeneron Pharmaceuticals Inc | REGN | 2.61% |
Structure Therapeutics Inc | GPCR | 2.57% |
United Laboratories International Holdings Ltd/The | 3933.HK | 2.44% |
Gubra A/S | GUBRA.CO | 2.13% |
MBX Biosciences Inc | MBX | 2.11% |
Gilead Sciences Inc | GILD | 1.69% |
Biohaven Ltd | BHVN | 1.58% |
Rhythm Pharmaceuticals Inc | RYTM | 1.53% |
Shionogi & Co Ltd | 4507.T | 1.19% |
WaVe Life Sciences Ltd | WVE | 0.77% |
First American Government Obligations Fund 12/01/2031 | FGXXX | 0.57% |
SWISS FRANC | CHF | 0.55% |
Corbus Pharmaceuticals Holdings Inc | CRBP | 0.36% |
Cash & Other | Cash...Other | 0.34% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
Roundhill Glp-1 & Weight Loss ETF (OZEM) share price today is $31.41.
Yes, Indians can buy shares of Roundhill Glp-1 & Weight Loss ETF (OZEM) on Vested. To buy OZEM from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Roundhill Glp-1 & Weight Loss ETF (OZEM) on Vested. You can start investing in Roundhill Glp-1 & Weight Loss ETF (OZEM) with a minimum investment of $1.
The 52-week high price of Roundhill Glp-1 & Weight Loss ETF (OZEM) is $37.15. The 52-week low price of Roundhill Glp-1 & Weight Loss ETF (OZEM) is $22.95.
The stock symbol (or ticker) of Roundhill Glp-1 & Weight Loss ETF is OZEM.
Yes, you can setup SIP in Roundhill Glp-1 & Weight Loss ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of OZEM on the Vested app.
The expense ratio of Roundhill Glp-1 & Weight Loss ETF (OZEM) is 0.59%.
Link copied